Skip to main content
. 2015 Oct 6;5:14495. doi: 10.1038/srep14495

Figure 2. Immunohistochemistry of patient 56 over several generations (F1 (A) and F2 (B)) and after established growth after storage using either the vitrification (Vitri) or the FCS/DMSO (FCS) protocol on either primary patient tumour tissue (F1) or tumour tissue harvested from previous generations (F2).

Figure 2

Magnification 10× and for CD31 20×.